| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Cordyceps Sunshine Biotech Holdings Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.04 |
| 52 Week High | US$0.04 |
| 52 Week Low | US$0.04 |
| Beta | 0 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| RAJA.F | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 0% | 0.5% | 4.0% |
| 1Y | n/a | -19.1% | 24.9% |
Return vs Industry: Insufficient data to determine how RAJA.F performed against the US Personal Products industry.
Return vs Market: Insufficient data to determine how RAJA.F performed against the US Market.
Price Volatility
| RAJA.F volatility | |
|---|---|
| RAJA.F Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 9.1% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.1% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: RAJA.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine RAJA.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | 15 | Szu Hao Huang | n/a |
Cordyceps Sunshine Biotech Holdings Co., Ltd. engages in the research, development, cultivation, processing, and sale of cordyceps for distributors and retail customers in China. It offers dry and fresh cordyceps, which is a species of parasitic fungus that is used as a Chinese medicinal material.
Cordyceps Sunshine Biotech Holdings Co., Ltd. Fundamentals Summary
| RAJA.F fundamental statistics | |
|---|---|
| Market cap | US$4.44m |
| Earnings (TTM) | US$241.54k |
| Revenue (TTM) | US$882.53k |
18.4x
P/E Ratio5.0x
P/S RatioIs RAJA.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RAJA.F income statement (TTM) | |
|---|---|
| Revenue | US$882.53k |
| Cost of Revenue | US$116.15k |
| Gross Profit | US$766.39k |
| Other Expenses | US$524.85k |
| Earnings | US$241.54k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0022 |
| Gross Margin | 86.84% |
| Net Profit Margin | 27.37% |
| Debt/Equity Ratio | -565.6% |
How did RAJA.F perform over the long term?
See historical performance and comparison